USE OF 4-(4-FLUORO-2-METHOXYPHENYL)-N--1,3,5-TRIAZIN-2-AMINE FOR TREATING LEUKEMIAS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15543228

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the use of 4-(4-Fluoro-2-methoxyphenyl)-N-{3-[(S-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine (compound A), more particularly (+)-4-(4-Fluoro-2-methoxyphenyl)-N-{3-[(S-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine (compound A′), for treating leukemias, in particular acute leukemias, preferably acute myeloid leukemias.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAYER PHARMA AKTIENGESELLSCHAFTGERMANY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
SCHOLZ, Arne Berlin, DE 42 286

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation